Salta al contenuto principale
Passa alla visualizzazione normale.

GIUSEPPE CICERO

Pubblicazioni

Data Titolo Tipologia Scheda
2022 Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study Articolo in rivista Vai
2021 Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting Articolo in rivista Vai
2021 Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab) Articolo in rivista Vai
2021 NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: A real-life study Articolo in rivista Vai
2021 Non-pegylated liposomal doxorubicin plus cyclophosphamide as first-line therapy in elderly women with HER2 negative metastatic breast cancer Articolo in rivista Vai
2020 Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): Efficacy, tolerability and Quality of Life Articolo in rivista Vai
2020 Tas-102 in metastatic colorectal cancer (MCRC): Efficacy, tolerability, and quality of life in heavily pretreated elderly patients: A real-life study Articolo in rivista Vai
2019 Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen Articolo in rivista Vai
2019 Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status Articolo in rivista Vai
2019 Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life Articolo in rivista Vai
2018 The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience Articolo in rivista Vai
2018 Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy Articolo in rivista Vai
2018 Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer Articolo in rivista Vai
2018 Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer Articolo in rivista Vai
2018 Psychological distress and quality of life in ostomy patients with colorectal cancer: A systematic review of the literature Articolo in rivista Vai
2017 Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer Articolo in rivista Vai
2017 WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY Proceedings (TIPOLOGIA NON ATTIVA) Vai
2017 The clinical efficacy of enzalutamide in metastatic prostate cancer: Prospective single-center study Articolo in rivista Vai
2017 The Role of Couples' Attachment Styles in Patients' Adjustment to Cancer Articolo in rivista Vai
2017 Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer Articolo in rivista Vai
2017 Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer Articolo in rivista Vai
2017 Role of densitometric criteria in evaluation of effectiveness of antiangiogenic therapies in metastatic colorectal cancer: An Italian clinical experience Articolo in rivista Vai
2017 Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? Articolo in rivista Vai
2017 Unusual case of dorsal vertebral metastases from a male breast cancer Articolo in rivista Vai
2017 Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study Articolo in rivista Vai
2017 Treatment with abiraterone in metastatic castration-resistant prostate cancer patients progressing after docetaxel: A retrospective study Articolo in rivista Vai
2017 Whatsapp messenger as a tool for the multidisciplinary management in everyday clinical practice Proceedings (TIPOLOGIA NON ATTIVA) Vai
2016 A headlight on liquid biopsies: a challenging tool for breast cancer management Articolo in rivista Vai
2016 Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study Articolo in rivista Vai
2016 Impact of combination chemotherapy on toxicity in ovarian cancer: Systematic revision of literature and meta-analysis Articolo in rivista Vai
2016 The patient-physician relationship in the face of oncological disease: A review of literature on the emotional and psychological reactions of patients and physician Articolo in rivista Vai
2016 PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis Articolo in rivista Vai
2016 Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway Review essay (rassegna critica) Vai
2015 Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy Articolo in rivista Vai
2015 Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials? Articolo in rivista Vai
2015 Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy Articolo in rivista Vai
2015 New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? Articolo in rivista Vai
2015 A rare case of extra-intramedullary dorsal tanycitic ependymoma, radically removed with intraoperative neurophysiological monitoring Articolo in rivista Vai
2015 Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? Articolo in rivista Vai
2015 Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? Articolo in rivista Vai
2015 CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY Proceedings (TIPOLOGIA NON ATTIVA) Vai
2014 Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects Articolo in rivista Vai
2014 Evaluation of anxiety level in patients wating to undergo to diagnostic radiological exams Proceedings (TIPOLOGIA NON ATTIVA) Vai
2014 Ramucirumab and its use in gastric cancer treatment Articolo in rivista Vai
2014 Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? Articolo in rivista Vai
2014 Well-being among Italian medical oncologists: An exploratory study Articolo in rivista Vai
2014 Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? Articolo in rivista Vai
2014 Targeted Therapies in Hepatocellular Carcinoma Articolo in rivista Vai
2014 Gene expression profiling of cumulus oophorus cells reveals altered pathways in patients with endometriosis Proceedings (TIPOLOGIA NON ATTIVA) Vai
2014 Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer Articolo in rivista Vai
2014 The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis Articolo in rivista Vai
2013 Leptin plasma levels in patients undergoing prostate biopsy. a preliminary study in 50 patients Proceedings (TIPOLOGIA NON ATTIVA) Vai
2013 Correlation between leptin plasmatic levels in non-obese patients and detection rate at prostate biopsy”- Poster P147 Proceedings (TIPOLOGIA NON ATTIVA) Vai
2013 Heterogeneity and prognostic influence of tumor- infiltrating γδ T lymphocytes in colon cancer patients Proceedings (TIPOLOGIA NON ATTIVA) Vai
2013 HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions Articolo in rivista Vai
2013 MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets Articolo in rivista Vai
2013 Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines Articolo in rivista Vai
2013 Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. Articolo in rivista Vai
2013 The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population Articolo in rivista Vai
2013 Co-expression of CD133+/CD44+in human colon cancer and liver metastasis Articolo in rivista Vai
2013 Studio pilota sul valore predittivo dei livelli plasmatici di 9 fattori angiogenetici nella selezione di pazienti candidati alla biopsia prostatica Articolo in rivista Vai
2013 Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations Articolo in rivista Vai
2013 Monoclonal antibodies in gastrointestinal cancers Articolo in rivista Vai
2013 Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells. Articolo in rivista Vai
2013 The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? Articolo in rivista Vai
2013 Does Exist A Correlation Between BMI and Gleason Patterns 4 and 5 At Prostate Biopsy? Articolo in rivista Vai
2013 Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting Articolo in rivista Vai
2013 Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vc9Vd2 T Cell-Mediated Cytotoxicity Articolo in rivista Vai
2013 Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? Articolo in rivista Vai
2012 MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? Articolo in rivista Vai
2012 Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas Articolo in rivista Vai
2012 The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies Articolo in rivista Vai
2012 How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? Articolo in rivista Vai
2012 Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? Articolo in rivista Vai
2012 Geldanamycin and its derivatives as Hsp90 inhibitors Articolo in rivista Vai
2012 What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? Articolo in rivista Vai
2012 Circulating exosomal Hsp60 as a new marker of colon cancer. Proceedings (TIPOLOGIA NON ATTIVA) Vai
2011 HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY Articolo in rivista Vai
2011 Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: an italian clinical axperience Articolo in rivista Vai
2011 Primary Non-Hodgkin’s lymphoma of the parotid gland Articolo in rivista Vai
2010 In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Articolo in rivista Vai
2010 Bortezomib: a new pro-apoptotic agent in cancer treatment. Articolo in rivista Vai
2010 Vg9Vd2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies Articolo in rivista Vai
2009 Terapia medica e supporto psicologico in un gruppo di pazienti affette da carcinoma mammario Articolo in rivista Vai
2009 I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio Capitolo o Saggio Vai
2008 Aminobisphosphonates as New Weapons for gammaDelta T Cell-Based Immunotherapy of Cancer Articolo in rivista Vai
2007 Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. Articolo in rivista Vai
2007 Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Articolo in rivista Vai
2007 Studio di fase II con Gemcitabine + Oxaliplatino in combinazione nel trattamento delle neoplasie delle vie biliari, pancreas e colecisti in fase metastatica. Altro Vai
2007 Studio di fase II con Taxotere + Doxorubicina liposomiale + Trastuzumab nel trattamento del carcinoma mammario metastatico c-erb-B2 positivo Altro Vai
2007 Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features Articolo in rivista Vai
2006 Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. Articolo in rivista Vai
2006 A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy Articolo in rivista Vai
2006 Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers Articolo in rivista Vai
2006 A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma Articolo in rivista Vai
2006 Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas Articolo in rivista Vai
2006 Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study Articolo in rivista Vai
2005 Emergenze metaboliche Capitolo o Saggio Vai
2005 The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers Articolo in rivista Vai
2005 Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. Articolo in rivista Vai
2005 Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. Articolo in rivista Vai
2004 Cardiotossicità e Cardioprotezione. Altro Vai
2004 La terapia adiuvante nel carcinoma del colon: un update della lettaratura Altro Vai